Nov 9 (Reuters) - Oncology Institute Inc TOI.O :
* THE ONCOLOGY INSTITUTE REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND UPDATES FULL YEAR 2022 GUIDANCE
* ONCOLOGY INSTITUTE INC Q3 REVENUE ROSE 24.3 PERCENT TO
$65.0
MILLION
* ONCOLOGY INSTITUTE INC - QTRLY LOSS PER SHARE $0.17
* ONCOLOGY INSTITUTE INC - TAKING MULTI-PRONGED APPROACH TO
COST
REDUCTION, INCLUDING REDUCTION OF VENDOR & CONTRACT SPEND &
WORKFORCE REDUCTION IN FY22
* ONCOLOGY INSTITUTE INC - EXPECT TO REALIZE BENEFITS FROM
COST
REDUCTION EFFORTS BEGINNING IN Q4 OF 2022
* ONCOLOGY INSTITUTE INC SEES FY22 REVENUE BETWEEN $245
MILLION TO
$250 MILLION
Source text for Eikon: ID:nGNX1s3wpM
Further company coverage: TOI.O
((Reuters.Briefs@thomsonreuters.com;))